Search

everythinglearnresearchcommunity

for

Search:↓

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

FDA-approved medications are important for treating high blood pressure in children, but non-approved ones can be used if needed.

Non-classical 21-hydroxylase deficiency can be missed in newborn screenings and should be considered in cases of early puberty or virilization.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Hes1 protein is important for hair growth and regeneration, and could be a potential treatment for hair loss.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

New hybrid compound found to effectively prevent hair loss.

HDMHG0401-10 improves hair loss in men with androgenetic alopecia and has no major side effects.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

A new genetic change in the keratin 10 gene caused a skin condition called ichthyosis hystrix in a father and his daughter.

Hairless protein can block vitamin D activation in skin cells.

A new genetic mutation linked to Hutchinson-Gilford progeria syndrome was found in China.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

A rare genetic disease causes sparse hair and early blindness due to a gene mutation.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

Adalimumab helped control a child's severe eye disease when other treatments failed.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Biotin mega-dose therapy led to dramatic improvement in a newborn with a rare metabolic disorder.

Nonclassic 21-hydroxylase deficiency is a common, treatable genetic disorder causing reversible symptoms like acne and hair loss.

A new ARID1B gene variation causes Coffin-Siris syndrome 1 and early high myopia in a Chinese family.

Vitamin D receptor mutations can cause alopecia by affecting hair growth genes.

SHH protein helps nerve regeneration in hypertensive rats.

Hairless protein can both repress and activate vitamin D receptor functions, affecting gene regulation.

HDMHG0401-10 treatment significantly improved hair count and was better than a placebo in reducing hair loss in men with hereditary hair loss, with no major side effects.

Scientists now better understand the genetics of hypohidrotic ectodermal dysplasia, leading to more accurate diagnoses and potential new treatments.

The study found that certain mutations in the vitamin D receptor can cause rickets and potentially affect hair growth.

Certain genetic variants impair enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

Early diagnosis and treatment of hereditary vitamin D-resistant rickets (HVDRR) are crucial to prevent growth issues and other health problems.